Virpax Pharmaceuticals Inc. Made Headway
Mon, Jul 08, 2024 at 07:20 PM
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ) soared at $1.11, a gain of 92%. On Mon, Jul 08, 2024, VRPX:NASDAQ touched a New 2-Week High of $1.11. The stock appeared on our News Catalysts scanner on Mon, Jul 08, 2024 at 02:29 PM in the 'ACQUISITION' category. From Mon, Jun 24, 2024, the stock recorded 55.56% Up Days and 20.00% Green Days
About Virpax Pharmaceuticals Inc. (VRPX:NASDAQ)
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management.
Top 10 Gainers:
- Shapeways Holdings Inc. (SHPW:NASDAQ), 132.19%
- Shapeways Holdings Inc. (SHPW:NYSE), 132.19%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 127.03%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 99.33%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 92.04%
- Morphic Holding, Inc. (MORF:NASDAQ), 75.06%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Myomo, Inc. (MYO:NYSEMKT), 41.81%